Mukti's FotoPage

By: Mukti Yousif

[Recommend this Fotopage] | [Share this Fotopage]
View complete fotopage

Sunday, 1-Dec-2013 15:37 Email | Share | Bookmark
Endoscopy Overused In Heartburn Patients












In the procedure, a doctor inserts an endoscope, a thin flexible tube equipped with a camera and a light, through the mouth of a sedated patient and into the esophagus , stomach , and first portion of the small intestine. Despite a lack of supporting evidence, the authors write, doctors routinely use endoscopy to diagnose and manage gastroesophageal reflux disease, or GERD , which develops when stomach acid leaks into the esophagus. As many as 40% of U.S. adults report having some GERD symptoms -- namely heartburn and regurgitation. Looking for Barretts Doctors use endoscopy in GERD patients mainly to check for a condition called Barrett's esophagus , which affects about 10% of people whove had chronic heartburn for at least five years, says Nicholas Shaheen, MD, MPH, an author of the new advice paper. Barretts occurs when stomach acids damage the lining of the esophagus. GERD and Barrett's esophagus have been linked to an increased risk of a type of cancer called esophageal adenocarcinoma. Although the overall risk for the cancer is still low, esophageal adenocarcinoma, which used to represent only a small minority of cancers in the esophagus, has increased 500% since the 1970s. It now accounts for more than half the cases in the U.S., says Shaheen, a gastroenterologist who directs the Center for Esophageal Diseases and Swallowing at the University of North Carolina, Chapel Hill. While smoking and drinking are stronger risk factors for another cancer type of the esophagus, the rise of esophageal adenocarcinoma is thought to be tied to the U.S. <br><br>his explanation http://www.webmd.com/heartburn-gerd/news/20121129/endoscopy-overused-heartburn












Solos Endoscopy Announces the MammoView(R) Breast Cancer Global Initiative for 2014





The Solos Endoscopy MammoView Breast Endoscopy System can offer women a positive prognosis for recovery by detecting breast cancer up to six times faster than conventional methods. The MammoView instrument line allows physicians to distinguish and inspect suspicious pre-cancerous lesions undetectable by other methods. "The MammoView Breast Cancer Global Initiative is more than just awareness, it's about education, and choices for women.October is over; people and businesses nationwide will take down their pink ribbons and pink signs, yet women all over the world will still be battling breast cancer.Solos Endoscopy will continue its efforts to fight breast cancer not just in October but throughout the year," stated Robert Segersten, President of Solos Endoscopy. Solos Endoscopy instruments are FDA approved. Solos Endoscopy intends to place the CE Mark on its entire MammoView instrument line with proper approval which will allow the instrument line to be sold globally starting in 2014. About Solos Endoscopy, Inc.: Solos Endoscopy celebrated its 25th Year of providing quality innovative healthcare instruments to Hospitals across the Country. For more than 25 Years, from medical schools to hospitals, surgeons have trusted Solos Endoscopy to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of disease and medical conditions.Additional information on its FDA approved products is available on the Company's website at: www.solosendoscopy.com . Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. <br><br>next page http://finance.yahoo.com/news/solos-endoscopy-announces-mammoview-r-145117584.html



View complete fotopage


© Pidgin Technologies Ltd. 2016

ns4008464.ip-198-27-69.net